A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese

Journal of Infectious Diseases

Volumn 203, Issue 7, 2011, Pages 943-947

  An, Ping ^a   Winkler, Cheryl ^a   Guan, Li ^b   O'Brien, Stephen J ^a   Zeng, Zheng ^c   Yu, Yanyan ^c   Xu, Xiaoyuan ^c   Lu, Haiying ^c   Hu, Darong ^d   Wang, Rongbing ^e   Chen, Yifan ^e   Hao, Cunyi ^f   Zhou, Heping ^g   Han, Zhonghou ^h   Wang, Yuhua ^h   Sun, Xiewen ^h   Bao, Lidao ⁱ   Zhang, Xiping ⁱ   Guo, Dasi ^j   Zhang, Yaoxin ^k   Dou, Xiaoguang ^l   Wei, Lai ^m   Rui, Jingan ⁿ   Qu, Qiang ⁿ   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f Beijing Institute of Tumor Prevention and Therapy   (China)

^g SHANXI MEDICAL UNIVERSITY   (China)

^h No1 Hospital of Qinhuangdao   (China)

ⁱ INNER MONGOLIA MEDICAL COLLEGE   (China)

^j Department of Infectious Diseases   (China)

^k XINJIANG MEDICAL UNIVERSITY   (China)

^l CHINA MEDICAL UNIVERSITY   (China)

^m PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

ⁿ PEKING UNION MEDICAL COLLEGE   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN; HLA DPA1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; VIRUS RESISTANCE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HLA-DP ANTIGENS; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VIRAL LOAD;

EID: 79953015941     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq154     Document Type: Article

References (15)

1. Yu MW, Hsu FC, Sheen IS, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997; 145:1039-47.
2. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004;38:S158-68.
3. Alward WL, McMahon BJ, Hall DB, Heyward WL, Francis DP, Bender TR. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis 1985; 151:604-9. (Pubitemid 15102155)
4. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 2007; 45:1187-92.
5. Yuen MF, Wong DK, Sablon E, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology 2004; 39:1694-701. (Pubitemid 38702671)
6. Thio CL, Thomas DL, Karacki P, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003; 77:12083-7. (Pubitemid 37345173)
7. Thomas HC, Foster GR, Sumiya M, et al. Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 1996; 348:1417-9. (Pubitemid 26395237)
8. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332:1065-9.
9. Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41:591-5.
10. Zeng Z, Guan L, An P, Sun S, O'Brien SJ, Winkler CA. A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis 2008; 8:1.
11. Chinese medical association of infectious diseases and parasites and Chinese medical association of hepatology. Protocol of prevention and treatment in viral hepatitis. Chin J Hepatol 2000; 6:324-9.
12. Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27:6550-7.
13. Heinzen EL, Ge D, Cronin KD, et al. Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 2008; 6:e1.
14. Penna A, Del Prete G, Cavalli A, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997; 25:1022-7. (Pubitemid 27157151)
15. Hohler T, Reuss E, Evers N, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002; 360:991-5. (Pubitemid 35284111)